Literature DB >> 20187244

The behavior of alpha-synuclein in neurons.

Doris L Fortin1, Venu M Nemani, Ken Nakamura, Robert H Edwards.   

Abstract

Despite considerable evidence linking alpha-synuclein with membranes in vitro, it has proven difficult to demonstrate membrane association of the protein in vivo. alpha-Synuclein localizes to the nerve terminal, but biochemical experiments have not revealed a tight association with membranes. To address the dynamics of the protein in live cells, we have used photobleaching and found that alpha-synuclein exhibits high mobility, although distinctly less than an entirely soluble protein. Further, neural activity controls the distribution of alpha-synuclein, causing its dispersion from the synapse. In addition to the presumed role of alpha-synuclein dynamics in synaptic function, changes in its physiological behavior may underlie the pathological changes associated with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187244     DOI: 10.1002/mds.22722

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

1.  Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death.

Authors:  Laura A Volpicelli-Daley; Kelvin C Luk; Tapan P Patel; Selcuk A Tanik; Dawn M Riddle; Anna Stieber; David F Meaney; John Q Trojanowski; Virginia M-Y Lee
Journal:  Neuron       Date:  2011-10-06       Impact factor: 17.173

Review 2.  Physiological phenotype and vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez; Paul T Schumacker
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Can the lack of fibrillar form of alpha-synuclein in Lewy bodies be explained by its catalytic activity?

Authors:  Ivan A Kuznetsov; Andrey V Kuznetsov
Journal:  Math Biosci       Date:  2021-12-07       Impact factor: 2.144

4.  Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis.

Authors:  Arati Tripathi; Heba Alnakhala; Elizabeth Terry-Kantor; Andrew Newman; Lei Liu; Thibaut Imberdis; Saranna Fanning; Silke Nuber; Nagendran Ramalingam; Dennis Selkoe; Ulf Dettmer
Journal:  J Neurosci       Date:  2022-01-27       Impact factor: 6.709

5.  Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.

Authors:  Edward Rockenstein; Silke Nuber; Cassia R Overk; Kiren Ubhi; Michael Mante; Christina Patrick; Anthony Adame; Margarita Trejo-Morales; Juan Gerez; Paola Picotti; Poul H Jensen; Silvia Campioni; Roland Riek; Jürgen Winkler; Fred H Gage; Beate Winner; Eliezer Masliah
Journal:  Brain       Date:  2014-03-24       Impact factor: 13.501

6.  Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation.

Authors:  Céline Galvagnion; Alexander K Buell; Georg Meisl; Thomas C T Michaels; Michele Vendruscolo; Tuomas P J Knowles; Christopher M Dobson
Journal:  Nat Chem Biol       Date:  2015-02-02       Impact factor: 15.040

7.  Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein.

Authors:  James B Koprich; Tom H Johnston; Philippe Huot; M Gabriela Reyes; Maria Espinosa; Jonathan M Brotchie
Journal:  PLoS One       Date:  2011-03-07       Impact factor: 3.240

8.  Differential effects of dopamine signalling on long-term memory formation and consolidation in rodent brain.

Authors:  Nicole Reichenbach; Ulrike Herrmann; Thilo Kähne; Horst Schicknick; Rainer Pielot; Michael Naumann; Daniela C Dieterich; Eckart D Gundelfinger; Karl-Heinz Smalla; Wolfgang Tischmeyer
Journal:  Proteome Sci       Date:  2015-03-18       Impact factor: 2.480

Review 9.  Rafts, Nanoparticles and Neural Disease.

Authors:  Vishal Gulati; Ron Wallace
Journal:  Nanomaterials (Basel)       Date:  2012-08-06       Impact factor: 5.076

Review 10.  The Synaptic Function of α-Synuclein.

Authors:  Jacqueline Burré
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.